These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
180925-CF3 Organoborons.pdf (948.76 kB)

A Biocatalytic Platform for Synthesis of Chiral α-Trifluoromethylated Organoborons

submitted on 26.09.2018, 00:35 and posted on 26.09.2018, 14:07 by Xiongyi Huang, Marc Garcia-Borràs, Kun Miao, S. B. Jennifer Kan, Arjun Zutshi, K. N. Houk, Frances H. Arnold

There are few biocatalytic transformations that produce fluorine-containing molecules prevalent in modern pharmaceuticals. To expand the scope of biocatalysis for organofluorine synthesis, we have developed an enzymatic platform for highly enantioselective carbene B–H bond insertion to yield versatile α-trifluoromethylated (α-CF3) organoborons, an important class of organofluorine molecules that contain stereogenic centers bearing both CF3 and boron groups. In contrast to current ‘carbene transferase’ enzymes that use a limited set of simple diazo compounds as carbene precursors, this system based on Rhodothermus marinus cytochrome c (Rma cyt c) can accept a broad range of trifluorodiazo alkanes and deliver versatile chiral α-CF3 organoborons with total turnovers up to 2870 and enantiomeric ratios up to 98.5:1.5. Computational modeling reveals that this broad diazo scope is enabled by an active site environment that directs the alkyl substituent on the heme CF3-carbene intermediate towards the solvent-exposed face, thereby allowing the protein to accommodate diazo compounds with diverse structural features.


GM-124480, MCB-1513007, K99GM129419, OCI-1053575


Email Address of Submitting Author


California Institute of Technology



ORCID For Submitting Author


Declaration of Conflict of Interest

No conflict of interest.